What Are Your Product Safety Liability Exposures As a Manufacturer?

A design defect means the product was made exactly as intended, but the intended design itself creates unreasonable risk; a manufacturing defect means the product deviated from the design during production. Design defects are harder to defend because they require showing that the design was the safest reasonable alternative available at the time, considering cost, feasibility, and consumer expectations. Manufacturing defects are often easier to isolate because they involve a single production run or batch. Courts evaluate design defects using a risk-benefit test: Does the gravity of the foreseeable harm outweigh the burden of adopting a safer alternative? From a practitioner's perspective, manufacturers face greater exposure on design claims because they require disclosure of pre-sale testing, internal communications about known hazards, and cost-benefit analyses that juries often view skeptically.

Failure-to-warn liability arises when a manufacturer knew or should have known of a hazard but did not provide adequate warnings or instructions. The standard is not perfection; rather, courts ask whether the warning was reasonably calculated to reach users, was conspicuous, and conveyed the nature and extent of the risk in understandable language. Manufacturers are not required to warn of obvious hazards, but this obviousness defense is narrow and fact-specific. Post-sale discovery of hazards creates particular risk because regulatory agencies and plaintiffs will examine whether you issued recalls promptly or attempted to suppress information about known problems.

The CPSC can initiate investigations based on consumer complaints, injury reports, or internal intelligence. It may demand production of design documents, testing records, complaints, and sales data without a warrant. If the CPSC determines a product creates a substantial hazard, it can order a recall, issue safety standards, or refer the matter to the Department of Justice for criminal prosecution if the violation was knowing and willful. The CPSC's investigative scope is expansive, and cooperation decisions carry strategic weight: declining to cooperate triggers adverse inferences, but voluntary disclosure can support a good-faith defense if violations later emerge. Manufacturers should evaluate whether engaging counsel before CPSC contact preserves attorney-client privilege for internal investigations and legal advice.

New York's Attorney General and local consumer protection agencies can bring enforcement actions under state consumer protection statutes, General Business Law Section 349, and common-law theories. These state actions often proceed in parallel with CPSC investigations and private litigation. The New York County Supreme Court frequently handles product liability discovery disputes, and courts in that venue have established rigorous standards for production of design documents and internal communications about known defects. Delays in producing verified loss affidavits or notice of defect to the state can result in adverse inferences about consciousness of guilt, even if the delay was administrative rather than intentional.

Internal emails, meeting notes, and design documents discussing known hazards, cost-benefit trade-offs, or decisions not to implement safer alternatives are highly damaging. Plaintiffs' counsel will seek evidence that you knew of a risk but chose not to redesign or warn based on cost considerations. Quality assurance reports, field failure data, and consumer complaint logs are routinely produced and used to establish notice of defects. Testing data, including tests you conducted and tests you did not conduct, becomes central to demonstrating whether the hazard was foreseeable. Manufacturers should consider whether certain sensitive materials can be protected through attorney-client privilege or work-product doctrine, but these protections are narrow and fact-dependent. Proactive documentation of safety decisions, including reasons for design choices and risk assessments, can support a reasonableness defense if framed as part of a genuine safety evaluation process rather than a cost-driven decision.

Yes. Knowing violations of federal consumer protection statutes can result in criminal referrals. The Department of Justice may prosecute a corporation or individual officers for mail fraud, wire fraud, or violations of specific statutes if the violation was knowing and willful. Criminal exposure is rare but serious, particularly in cases involving concealment of known defects or obstruction of investigations. Your company should understand that settlement of civil claims does not preclude criminal prosecution, and communications with regulators can be used in criminal proceedings. Counsel experienced in both civil product liability and regulatory defense should evaluate the risk profile early, including whether any communications or conduct could be characterized as knowing concealment.

Document the defect, the scope of affected products, and any known injuries or complaints in writing. Preserve all testing data, design documents, communications about the hazard, and sales records. Do not destroy or alter any materials, even if they appear damaging; courts view spoliation as consciousness of guilt and impose severe sanctions. Notify your insurance carrier and counsel immediately so that investigation and legal advice can proceed under attorney-client privilege. Evaluate whether the defect requires immediate notification to the CPSC, state agencies, or consumers under applicable statutes and regulations. Coordinate with your regulatory and litigation counsel before issuing public statements or recalls, because inconsistent messaging across venues can undermine credibility and increase exposure. Consider whether you should engage consumer product injuries counsel to assess liability exposure and develop a response strategy that accounts for both administrative and litigation risk.

Settlement decisions must account for both the immediate litigation cost and the broader regulatory and reputational impact. A recall that is too narrow may invite regulatory criticism and additional litigation; a recall that is too broad may inflame class action claims and consumer confidence. Manufacturers often face pressure to settle quickly to avoid discovery disclosure, but premature settlement can signal weakness and invite copycat litigation. Evaluate whether the defect is isolated, how many consumers are affected, what injuries or losses have been reported, and whether the cost of a recall is proportionate to the actual hazard. Coordinate with your insurance counsel and regulatory advisors to ensure that settlement terms do not conflict with ongoing CPSC investigations or state enforcement actions. Forward-looking considerations include documenting the factual basis for your recall decision, preserving evidence of the investigation and risk assessment, and establishing clear procedures for handling future product safety concerns so that courts and regulators can assess your compliance culture.

Manufacturers should also recognize that product safety exposure often intersects with criminal and regulatory domains. If your company faces allegations of knowing concealment or willful violation, counsel specializing in bribery defense lawyer strategies and regulatory white-collar defense may be necessary to evaluate whether criminal exposure exists and to coordinate defense across civil and criminal tracks. The key strategic priority is to establish, through documentation and procedural record-making, that your company conducted a good-faith safety assessment, disclosed known hazards to regulators and consumers in a timely manner, and made design and warning decisions based on reasonable risk evaluation rather than cost avoidance. This record becomes critical if litigation proceeds to trial or if regulatory agencies later scrutinize your compliance posture.